Eliem Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Eliem Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Eliem Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eliem Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $40k | 5.8k | 6.85 |
| 2025-03-31 | $2.3M | 1.9M | 1.23 |
| 2024-12-31 | $41k | 23k | 1.80 |
| 2024-09-30 | $109k | 21k | 5.09 |
| 2024-06-30 | $12k | 1.6k | 7.11 |
| 2021-12-31 | $18k | 1.8k | 10.23 |